Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statement of Changes in Shareholders' Equity

v3.24.1.u1
Consolidated Statement of Changes in Shareholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Preferred Stock
Common Stock and Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2022 $ 273,197 $ 184 $ 28,397 $ 58,953 $ 207,003 $ 184 $ (21,156)
Beginning balance (in shares) at Dec. 31, 2022       7,996.8      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 8,161       8,161    
Net change in debt securities 555           555
Net change in debit valuation adjustments 10           10
Net change in derivatives 2,042           2,042
Employee benefit plan adjustments 10           10
Net change in foreign currency translation adjustments 12           12
Dividends declared:              
Common (1,774)       (1,774)    
Preferred (505)       (505)    
Common stock issued under employee plans, net, and other 519     $ 526 (7)    
Common stock issued under employee plans, net, and other (in shares)       42.4      
Common stock repurchased (2,215)     $ (2,215)      
Common stock repurchased (in shares)       (66.8)      
Ending balance at Mar. 31, 2023 280,196   28,397 $ 57,264 213,062   (18,527)
Ending balance (in shares) at Mar. 31, 2023       7,972.4      
Beginning balance at Dec. 31, 2023 291,646   28,397 $ 56,365 224,672   (17,788)
Beginning balance (in shares) at Dec. 31, 2023       7,895.5      
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 6,674       6,674    
Net change in debt securities 332           332
Net change in debit valuation adjustments (188)           (188)
Net change in derivatives (416)           (416)
Employee benefit plan adjustments 23           23
Net change in foreign currency translation adjustments (20)           (20)
Dividends declared:              
Common (1,910)       (1,910)    
Preferred (532)       (532)    
Common stock issued under employee plans, net, and other 443     $ 445 (2)    
Common stock issued under employee plans, net, and other (in shares)       44.0      
Common stock repurchased (2,500)     $ (2,500)      
Common stock repurchased (in shares)       (72.6)      
Ending balance at Mar. 31, 2024 $ 293,552   $ 28,397 $ 54,310 $ 228,902   $ (18,057)
Ending balance (in shares) at Mar. 31, 2024       7,866.9